ArticleCureus2024
Evaluation of Thyroid Function and Its Relation to Glycemic Status in Pregnant Women With Gestational Diabetes Mellitus.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and validation of a nomogram prediction model for thyroid dysfunction in patients with type 2 diabetes mellitus.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Gestational diabetes mellitus (GDM) is a prevalent complication during pregnancy that can lead to adverse outcomes for both the mother and the fetus. It also increases the likelihood of developing type 2 diabetes mellitus (T2DM) later in life. Thyroid hormones play an essential role in regulating growth and metabolism and often coexist with diabetes mellitus (DM), affecting glucose metabolism. Pregnant women with GDM frequently exhibit thyroid issues, impacting insulin secretion and beta-cell function. Aim This study aims to assess thyroid function and glycemic status in pregnant women with and without GDM and to evaluate the correlation between thyroid function and glycemic status in pregnant women with GDM. Methods This prospective case-control study was conducted over two months at a tertiary care hospital in Puducherry, India. It included 60 cases (pregnant women with GDM, blood glucose > 140 mg/dL per DIPSI guidelines) and 60 age- and parity-matched controls. Blood samples were collected, centrifuged, and analyzed for blood glucose and serum thyroid levels (FT3, FT4, thyroid-stimulating hormone (TSH)) using the Cobas e-411 autoanalyzer through an electrochemiluminescence assay. Results Serum plasma glucose levels were significantly higher in cases (159.25 ± 16.22 mg/dL) compared to controls (101.6 ± 17.30 mg/dL) (p < 0.05). FT3 levels were higher in cases (3.98 ± 4.18) compared to controls (2.87 ± 0.54) (p = 0.04). The FT3/FT4 ratio was also higher in cases (3.99 ± 4.927) than in controls (2.70 ± 0.58) (p = 0.04). No significant differences were found in FT4 or TSH levels between the groups. Correlation analysis revealed no significant correlations between plasma glucose levels and thyroid function parameters. Conclusion Pregnant women with GDM showed significantly higher plasma glucose levels, FT3 levels, and FT3/FT4 ratio compared to normal pregnant women. These findings suggest an association between altered thyroid function, particularly higher FT3 levels and the FT3/FT4 ratio, and GDM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.